{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021675","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.981284+00:00","generated_at":"2026-05-17T22:15:57.827378+00:00","sec_items":["1.01","3.02","5.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"InspireMD raises $58M via PIPE and warrant exercise; appoints Ray Cohen to board","bullets":["PIPE gross proceeds $40.1M: 16.6M shares/pre-funded warrants at $2.42/share; led by OrbiMed and Marshall Wace.","Warrant exercise yields $17.9M: 12.9M Series I warrants exercised at $1.3827, triggered by FDA PMA of CGuard Prime.","Combined $58M to fund U.S. commercial launch of CGuard Prime; intended use includes sales/marketing, R&D, working capital.","Raymond W. Cohen appointed to Board (Cl. 3), effective Aug 1; former CEO of Axonics (sold to BSX for $3.7B), brings MedTech scaling expertise.","Directors Kathryn Arnold and Thomas Kester will not stand for reelection in 2026; expected resignations by Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021675","json":"https://secwatch.observer/filing/0001641172-25-021675.json","markdown":"https://secwatch.observer/filing/0001641172-25-021675.md","text":"https://secwatch.observer/filing/0001641172-25-021675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/0001641172-25-021675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:15:57.827378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}